Zona Pellucida Glycoprotein 3 anticorps (C-Term)
-
- Antigène Voir toutes Zona Pellucida Glycoprotein 3 (ZP3) Anticorps
- Zona Pellucida Glycoprotein 3 (ZP3)
-
Épitope
- C-Term
-
Reactivité
- Humain, Boeuf (Vache), Cheval, Lapin
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Zona Pellucida Glycoprotein 3 est non-conjugé
-
Application
- Western Blotting (WB)
- Specificité
- Human ZP3
- Homologie
- Percent identity by BLAST analysis: Human, Bovine, Rabbit (100%).
- Purification
- Protein A purified
- Immunogène
-
Synthetic peptide from C-Terminus of human ZP3 (P21754-2). Percent identity by BLAST analysis: Human, Bovine, Rabbit, Horse (100%).
Type of Immunogen: Synthetic peptide - Isotype
- IgG
- Top Product
- Discover our top product ZP3 Anticorps primaire
-
-
- Indications d'application
- Approved: WB (0.6 μg/mL)
- Commentaires
-
Target Species of Antibody: Human
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- After adding water, will consist of PBS buffer with 2 % sucrose
- Concentration
- Lot specific
- Buffer
- Lyophilized from PBS with 2 % sucrose
- Conseil sur la manipulation
- Avoid repeat freeze-thaw cycles.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
- Antigène
- Zona Pellucida Glycoprotein 3 (ZP3)
- Autre désignation
- ZP3 (ZP3 Produits)
- Synonymes
- anticorps ZP3A, anticorps ZP3B, anticorps ZPC, anticorps Zp-3, anticorps zp3.2, anticorps Zp-3B, anticorps zona pellucida glycoprotein 3, anticorps zona pellucida sperm-binding protein 3, anticorps ZP3, anticorps zp3, anticorps Zp3
- Sujet
-
Name/Gene ID: ZP3
Synonyms: ZP3, Zona pellucida glycoprotein 3B, Zp-3, ZP3-424, ZP3A, ZP3B, ZP3-372, ZPC, Sperm receptor, Zona pellucida glycoprotein 3, Zona pellucida protein C - ID gène
- 7784
- UniProt
- P21754
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
-